Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel George, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- State University of Iowa
Iowa City, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Ochsner Clinic Foundation D/b/a Ochsner Health
New Orleans, Louisiana, United States
- the Johns Hopkins University
Baltimore, Maryland, United States
- the Regents of the University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- the University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- the Ohio State University
Columbus, Ohio, United States
- Geisinger Clinic
Danville, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- the University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- the Medical College of Wisconsin, Inc.
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 11 Feb 2026
- Registered enrollment
- 468
- Registry id
- NCT04919122
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.